ACR vs MAYS

ACR exhibits weak financial health with a Piotroski F-Score of just 2/9, signaling significant operational and balance sheet concerns. Despite strong recent earnings growth and profitability margins, the company's high leverage (Debt/Equity of 2.84) and extremely low valuation multiples like Price/Book of 0.32 suggest deep underlying risks. The absence of an Altman Z-Score due to insufficient data further clouds solvency assessment, while technical indicators and insider sentiment are neutral-to-bearish. Although the stock appears undervalued relative to the Graham Number ($35.84) and analyst target ($24.50), erratic earnings surprises and lack of dividend support undermine confidence in sustained recovery.

MAYS presents a concerning profile characterized by a stable but stagnant financial health baseline, as indicated by a Piotroski F-Score of 5/9. Despite a manageable debt-to-equity ratio, the company is struggling with negative profit margins (-3.90%) and contracting revenue growth both YoY (-7.70%) and Q/Q (-5.92%). The combination of a 0/100 technical trend and low insider sentiment (40/100) suggests a lack of confidence in near-term recovery. Overall, the company is a loss-making micro-cap with deteriorating top-line performance.